bpc-157 regulatory status approved drug BPC-157's FDA Review Raises Questions About Its Origins | American Peptide Society posted on the topic Gray market peptides blur drug
Description
Build the system first, then go live

The regulatory landscape could change

Think of it like pouring a beer along the side of a glass to prevent foam
Not all pain syndromes are of a single pathophysiological somatosensory origin
